Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ANXA6 contributors: shn/npt - updated : 04-03-2020
HGNC name annexin A6
HGNC id 544
DNA
TYPE functioning gene
STRUCTURE 57.10 kb     27 Exon(s)
10 Kb 5' upstream gene genomic sequence study
regulatory sequence Promoter (CAAT box) (TATA box)
MAPPING cloned Y linked N status confirmed
Map cen - D5S640 - D5S470 - ANXA6 - D5S2077 - D5S673 - qter
RNA
TRANSCRIPTS type messenger
text transcription start site contains TATAA and CAAT motifs
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
26 splicing 2889 75.87 673 - 2018 29636414
25 splicing 2871 75.15 667 - 2018 29636414
  • a 26 exons variant
  • missing exon 21
  • lacking VAAEIL (6 aminos acids) at the start of the seventh repeat of the eight protein repeat motif
  • 25 - 2898 - 641 - 2018 29636414
    EXPRESSION
    Type ubiquitous
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularvessel   moderately
    Digestiveliver     Homo sapiens
    Lymphoid/Immunespleen   highly
     thymus   moderately
    Nervousnerve   highly
    Urinarykidney   moderately
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Blood / hematopoieticbone marrow  predominantly
    cells
    SystemCellPubmedSpeciesStageRna symbol
    not specificchondrocyte Homo sapiens
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • a relatively short N terminus
  • a C terminal "core" region containing four repeats homolog to the endonexin fold
  • contains 8 annexin repeats
  • conjugated PhosphoP , Other
    HOMOLOGY
    interspecies ortholog to anxa6, Danio rerio
    ortholog to ANXA6, Pan troglodytes
    ortholog to Anxa6, Rattus norvegicus
    ortholog to Anxa6, Mus musculus
    Homologene
    FAMILY
  • calcium-dependent membrane and phospholipid binding protein
  • annexin family
  • CATEGORY regulatory , transport
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,mitochondria
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,peroxisome
    intracellular,cytoplasm,organelle,endosome
    intracellular,cytoplasm,cytosolic
    basic FUNCTION
  • mediating the endosome aggregation and vesicle fusion in secreting epithelia during exocytosis
  • regulating the release of calcium Ca2+ from intracellular strores
  • a retinoid binding activity
  • putative roles in adhesion-related cellular processes that contribute to breast cancer progression
  • may play a particular role in the organization of lipid microdomains in Niemann-Pick disease
  • in the presence of calcium, ANXA6 re-located to the fractions enriched in detergent-resistant microdomains only in the Niemann-Pick disease cells, suggestive of ANXA6 participation in organization of these microdomains
  • ANXA6 via its stimulatory actions on PRKCA and its role in mediating Ca(2+) flux across membranes regulates terminal differentiation and mineralization events of chondrocytes
  • ANXA6-induced plasma membrane remodelling indicated that elevated ANXA6 expression decreased membrane order through the regulation of cellular cholesterol homeostasis and the actin cytoskeleton
  • ANXA6 protein in adipocytes was upregulated by oxidative stress which might trigger ANXA6 induction in adipose tissues and contribute to impaired fat storage and adiponectin release
  • implicated in many biological processes, including cell proliferation, survival, differentiation, inflammation, but also membrane repair and viral infection
  • novel role for ANXA6 in articular chondrocytes via its modulation of WNT/CTNNB1 and NFKB1 signaling activities and the cross-talk between these two signaling pathways
  • controls cholesterol and membrane transport in endo- and exocytosis, and modulates triglyceride accumulation and storage
  • acts as a scaffolding protein for negative regulators of growth factor receptors and their effector pathways in many different cell types
  • is a novel gatekeeper that controls cellular distribution of late endosome-cholesterol via regulation of a RAB7-GAP and membrane contact sites (MCS) formation
  • stabilize and establish the formation of multifactorial signaling complexes
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS exocytosis transport
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule metal binding, other,
  • calcium Ca2+
  • phospholipid
  • vitamin A (all-trans retinol)
  • protein
  • CD21
  • Ras p21 regulatory protein p120GAP
  • Ca(2+)-regulated EF-hand proteins S100A1 and S100B
  • EBV/C3d receptor (CR2)
  • active H-Ras (HRasG12V)
  • ANXA6 inhibits DNM1L activity, and Ca2+-binding to ANXA6 relieves this inhibition to permit DNM1L-mediated mitochondrial fission
  • cooperative mechanism where ANXA6 potentiates NPPA-dependent counterhypertrophic responses in cardiomyocytes by facilitating regulated traffic of pro-NPPA
  • elevated ANXA6 levels cause late endosome (LE) cholesterol accumulation, ANXA6 and blockage of LE cholesterol transport are critical for endosomal function required for STX6-mediated recycling of integrins in cell migration
  • PLA2G4A -dependent pathways contribute to the novel regulatory role of hepatic ANXA6 in lipid droplet (LD) formation
  • ANXA6 acts as a scaffold for RASGRF2 and RAS proteins and its interaction with RASGRF2 is modulated by GTP and/or activation of Ras proteins
  • cell & other
  • cytoskeleton in a calcium-dependent manner
  • interacts with membranes in a Ca2+-dependent manner
  • REGULATION
    induced by EBV
    Other phosphorylated in response to growth factor stimulation
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    contributes to breast cancer progression by promoting the loss of functional cell-cell and/or cell-ECM contacts and anchorage-independent cell proliferation
    tumoral     --low  
    is specifically reduced in human hepatocellular carcinoma suggesting a role of this protein in hepatocarcinogenesis
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    miscelleaneouspain 
    annexin A6 can be exploited to inhibit chronic mechanical pain
    ANIMAL & CELL MODELS
  • Annexin A6-deficient mice showed increased sensitivity to mechanical stimuli